Join us for an in-depth exploration of the latest advancements in Antibody-Drug Conjugates (ADCs), where leading experts will present groundbreaking research, emerging clinical trial data, and innovative therapeutic strategies. This dynamic program is designed to deepen your understanding of ADCs and their evolving role in modern oncology, with a focus on improving patient outcomes through…